This paper describes pharmaceutical pricing and reimbursement policies in Germany, considering them in the broader … out-of-pocket payments may impair affordability for the poorest part of the population. Germany does not regulate ex …- manufacturer prices of pharmaceuticals at market entry (though distribution margins are regulated for reimbursed drugs). On the …